Related references
Note: Only part of the references are listed.Genetic Disruption of Lactate/H+ Symporters (MCTs) and Their Subunit CD147/BASIGIN Sensitizes Glycolytic Tumor Cells to Phenformin
Ibtissam Marchiq et al.
CANCER RESEARCH (2015)
A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer
Nelma Pertega-Gomes et al.
BMC CANCER (2014)
Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis
Joanne R. Doherty et al.
CANCER RESEARCH (2014)
Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets
Vera Miranda-Goncalves et al.
NEURO-ONCOLOGY (2013)
Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer
Nelma Pertega-Gomes et al.
PROSTATE (2013)
Transport metabolons with carbonic anhydrases
Joachim W. Deitmer et al.
FRONTIERS IN PHYSIOLOGY (2013)
Carbohydrate restriction and lactate transporter inhibition in a mouse xenograft model of human prostate cancer
Howard S. Kim et al.
BJU INTERNATIONAL (2012)
Is cancer a metabolic rebellion against host aging? In the quest for immortality, tumor cells try to save themselves by boosting mitochondrial metabolism
Adam Ertel et al.
CELL CYCLE (2012)
Multiple Biological Activities of Lactic Acid in Cancer: Influences on Tumor Growth, Angiogenesis and Metastasis
Suveera Dhup et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Role of monocarboxylate transporters in human cancers: state of the art
Celine Pinheiro et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2012)
Targeting glucose metabolism for cancer therapy
Robert B. Hamanaka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Targeting the Lactate Transporter MCT1 in Endothelial Cells Inhibits Lactate-Induced HIF-1 Activation and Tumor Angiogenesis
Pierre Sonveaux et al.
PLOS ONE (2012)
Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer
Nelma Pertega-Gomes et al.
BMC CANCER (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
Charles E. Massie et al.
EMBO JOURNAL (2011)
Targeting cancer metabolism: a therapeutic window opens
Matthew G. Vander Heiden
NATURE REVIEWS DRUG DISCOVERY (2011)
CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors
Renaud Le Floch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review
Paolo E. Porporato et al.
FRONTIERS IN PHARMACOLOGY (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression
J. Hao et al.
BRITISH JOURNAL OF CANCER (2010)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts
Zongxiang Zhou et al.
CANCER RESEARCH (2007)
Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles
Daniel R. Rhodes et al.
NEOPLASIA (2007)
Hypoxia increases androgen receptor activity in prostate cancer cells
Soo-Yeon Park et al.
CANCER RESEARCH (2006)
Potent blockers of the monocarboxylate transporter MCT1: Novel immunomodulatory compounds
SD Guile et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Altered metabolism and mitochondrial genome in prostate cancer
GD Dakubo et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
S Varambally et al.
CANCER CELL (2005)
Mitochondrial function, zinc, and intermediary metabolism relationships in normal prostate and prostate cancer
LC Costello et al.
MITOCHONDRION (2005)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Share Paper
